Skip to content

STERIS plc

NYSE: STE · USD

STERIS plc revenue100

Quarterly and annual revenue from company filings.

Business drivers

Business lines and operating measures.

Total Healthcare Revenues

Reported quarterly Total Healthcare Revenues. Quarterly figures · USD

Total Healthcare Revenues. Reported quarterly Total Healthcare Revenues. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Jun 30, 2026From Apr 1, 20261,048,300,000Filed Aug 7, 2026
Dec 31, 2025From Oct 1, 20251,063,800,000Filed Feb 6, 2026
Jun 30, 2025From Apr 1, 2025974,700,000Filed Aug 7, 2026
Dec 31, 2024From Oct 1, 2024976,000,000Filed Feb 6, 2026

Total AST Revenues

Reported quarterly Total AST Revenues. Quarterly figures · USD

Total AST Revenues. Reported quarterly Total AST Revenues. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Jun 30, 2026From Apr 1, 2026297,600,000Filed Aug 7, 2026
Dec 31, 2025From Oct 1, 2025286,600,000Filed Feb 6, 2026
Jun 30, 2025From Apr 1, 2025281,200,000Filed Aug 7, 2026
Dec 31, 2024From Oct 1, 2024258,100,000Filed Feb 6, 2026

Total Life Sciences Revenues

Reported quarterly Total Life Sciences Revenues. Quarterly figures · USD

Total Life Sciences Revenues. Reported quarterly Total Life Sciences Revenues. Unit: USD. All reporting dates and source links follow.
Period endedUSDReport
Jun 30, 2026From Apr 1, 2026146,700,000Filed Aug 7, 2026
Dec 31, 2025From Oct 1, 2025145,800,000Filed Feb 6, 2026
Jun 30, 2025From Apr 1, 2025135,200,000Filed Aug 7, 2026
Dec 31, 2024From Oct 1, 2024136,400,000Filed Feb 6, 2026

Independent series; they may overlap and do not form an additive breakdown.

  • The supplied observations are intermittent rather than a complete sequential history.
  • Selected series measure business activity through revenue rather than operating volumes.

Products & projects

instrument and scope repair

These include: consumable products, such as detergents, endoscopy accessories, barrier products, instruments and tools; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair, laboratory testing, and outsourced reprocessing; capital equipment, such as sterilizers, surgical tables, and automated endoscope reprocessors; and connectivity solutions such as operating room integration.

Filed · source for instrument and scope repair

Revenue history

USD millions · Fiscal periods
Mar 31, 2019 through Jun 30, 2026

Quarterly data

STERIS plc quarterly financial data in USD millions. FY denotes the company's fiscal year. YTD covers reported quarters only.
Fiscal quarterEndedTotal revenueUSD millions
FY 2027 Q1Jun 30, 20261,492.7, −6.0% versus FY 2026 Q4
FY 2026 Q4Mar 31, 20261,588.4, +6.2% versus FY 2026 Q3
FY 2026 Q3Dec 31, 20251,496.2, +2.5% versus FY 2026 Q2
FY 2026 Q2Sep 30, 20251,460.3, +5.0% versus FY 2026 Q1
FY 2026 Q1Jun 30, 20251,391.1, −6.0% versus FY 2025 Q4
FY 2025 Q4Mar 31, 20251,480.531, +8.0% versus FY 2025 Q3
FY 2025 Q3Dec 31, 20241,370.57, +3.1% versus FY 2025 Q2
FY 2025 Q2Sep 30, 20241,328.912, +3.9% versus FY 2025 Q1
FY 2025 Q1Jun 30, 20241,279.502, −9.9% versus FY 2024 Q4
FY 2024 Q4Mar 31, 20241,419.387, +1.7% versus FY 2024 Q3
FY 2024 Q3Dec 31, 20231,395.645, +4.0% versus FY 2024 Q2
FY 2024 Q2Sep 30, 20231,342.36, +4.5% versus FY 2024 Q1
FY 2024 Q1Jun 30, 20231,284.542, +0.3% versus FY 2023 Q4
FY 2023 Q4Mar 31, 20231,281.252, +5.4% versus FY 2023 Q3
FY 2023 Q3Dec 31, 20221,215.994, +1.3% versus FY 2023 Q2
FY 2023 Q2Sep 30, 20221,200.517, +3.8% versus FY 2023 Q1
FY 2023 Q1Jun 30, 20221,156.491, −4.5% versus FY 2022 Q4
FY 2022 Q4Mar 31, 20221,210.686, +0.1% versus FY 2022 Q3
FY 2022 Q3Dec 31, 20211,208.971, +1.0% versus FY 2022 Q2
FY 2022 Q2Sep 30, 20211,196.985, +23.6% versus FY 2022 Q1
FY 2022 Q1Jun 30, 2021968.422, +10.9% versus FY 2021 Q4
FY 2021 Q4Mar 31, 2021873.531, +8.0% versus FY 2021 Q3
FY 2021 Q3Dec 31, 2020808.924, +7.0% versus FY 2021 Q2
FY 2021 Q2Sep 30, 2020756.132, +13.0% versus FY 2021 Q1
FY 2021 Q1Jun 30, 2020668.932, −18.7% versus FY 2020 Q4
FY 2020 Q4Mar 31, 2020822.991, +6.3% versus FY 2020 Q3
FY 2020 Q3Dec 31, 2019774.261, +5.1% versus FY 2020 Q2
FY 2020 Q2Sep 30, 2019736.84, +5.7% versus FY 2020 Q1
FY 2020 Q1Jun 30, 2019696.803, Change unavailable versus FY 2019 Q4
Sources and definitions

Figures from official company filings and financial reports, in the reported currency. FY identifies the fiscal year; the end date identifies the calendar period. Last checked Oct 19, 2026.

Annual values come from annual filings. Historical quarters retain their reporting basis; rounding and reclassifications can make their sum differ from the annual figure. YTD sums the available fiscal quarters and compares the same quarters of the previous fiscal year.

Missing values are shown as unavailable. Fourth quarters use reported values where available, otherwise the annual amount less the matching nine-month amount.

Total revenue
Reported consolidated revenue from the issuer filing. Each observation identifies its accounting concept; bank net revenue is net of interest expense when that concept is reported.
Annual and quarterly differences
  • FY 2023 · Total revenue: annual 4,957.839, quarter sum 4,854.254 USD millions.
  • FY 2024 · Total revenue: annual 5,138.701, quarter sum 5,441.934 USD millions.
  • FY 2026 · Total revenue: annual 5,935.9, quarter sum 5,936 USD millions.